Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies (Q37625670)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 October 2009

Language	Label	Description	Also known as
English	Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies	scientific article published on 30 October 2009

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies (English)

1 reference

Europe PubMed Central

21 August 2017

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

cardiovascular disease

1 reference

based on heuristic

inferred from title

author name string

Roland Klingenberg

1

1 reference

Europe PubMed Central

21 August 2017

Göran K Hansson

2

1 reference

Europe PubMed Central

21 August 2017

publication date

30 October 2009

1 reference

Europe PubMed Central

21 August 2017

European Heart Journal

1 reference

Europe PubMed Central

21 August 2017

30

1 reference

Europe PubMed Central

21 August 2017

23

1 reference

Europe PubMed Central

21 August 2017

2838-2844

1 reference

Europe PubMed Central

21 August 2017

Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Major risk factors as antecedents of fatal and nonfatal coronary heart disease events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Premature coronary-artery atherosclerosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Immunological and inflammatory functions of the interleukin-1 family

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Enhanced T-cell expression of RANK ligand in acute coronary syndrome: possible role in plaque destabilization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Increased plasma concentrations of interleukin-18 in acute coronary syndromes.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Oral fingolimod (FTY720) for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Sphingosine-1-phosphate analogue FTY720 causes lymphocyte redistribution and hypercholesterolemia in ApoE-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Drug insight: Immunomodulatory effects of statins--potential benefits for renal patients?

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

C-reactive protein levels and outcomes after statin therapy

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Effects of anti-TNF-alpha treatment on lipid profile in patients with active rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Anti-tumour necrosis factor (TNF)-alpha therapy (etanercept) down-regulates serum matrix metalloproteinase (MMP)-3 and MMP-1 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Osteoprotegerin promotes fibrous cap formation in atherosclerotic lesions of ApoE-deficient mice--brief report.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Investigation of the effect of Interleukin-1 receptor antagonist (IL-1ra) on markers of inflammation in non-ST elevation acute coronary syndromes (The MRC-ILA-HEART Study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

5-lipoxygenase: regulation and possible involvement in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Increased urinary leukotriene excretion in patients with cardiac ischemia. In vivo evidence for 5-lipoxygenase activation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Leukotriene B4 signaling through NF-kappaB-dependent BLT1 receptors on vascular smooth muscle cells in atherosclerosis and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Cytokine network and T cell immunity in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) pathway attenuates atherogenesis in low-density lipoprotein receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Isolation, expansion, and characterization of human natural and adaptive regulatory T cells

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Vaccination against atherosclerosis? Induction of atheroprotective immunity

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Genetic and Acquired Inflammatory Conditions Are Synergistically Associated With Early Carotid Atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP477

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHP477

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37625670&oldid=1716024214"